Document:

EX-10.3

 Exhibit 10.3 

Execution Version 

SPONSOR SUPPORT AGREEMENT 
 This
Sponsor Support Agreement (this “Agreement”) is dated as of December 22, by and among dMY Technology Group, Inc. VI, a Delaware corporation (“dMY”), dMY Sponsor VI, LLC, a Delaware limited liability
company (the “Sponsor”), each of the undersigned individuals, each of whom is a member of dMY’s board of directors and/or management team (each, an “Insider” and collectively, the
“Insiders” and together with the Sponsor, the “dMY Holders”) and Rain Enhancement Technologies, Inc., a Delaware corporation (the “Company”). Capitalized terms used but not
defined herein shall have the respective meanings ascribed to such terms in the Share Purchase Agreement (defined below). 
 RECITALS

 WHEREAS, as of the date hereof, each dMY Holder is the holder of record and the “beneficial owner” (within the meaning of Rule 13d-3 under the Exchange Act) of certain shares of dMY Class A Common Stock, par value $0.0001 per share (“dMY Class A Common Stock”), dMY Class B
Common Stock, par value $0.0001 per share (“dMY Class B Common Stock” and together with the dMY Class A Common Stock, “dMY Common Stock”), and warrants exercisable
for shares of dMY Class A Common Stock (the “dMY Warrants”) in each case as set forth on Schedule I attached hereto (all such securities or other equity securities, together with any shares of dMY’s capital
stock or other equity securities of which ownership of record or the power to vote (including, without limitation, by proxy or power of attorney) is hereafter acquired by any such dMY Holder during the period from the date hereof through the
Expiration Time are referred to herein as the “Subject Securities”); 
 WHEREAS, contemporaneously with the execution and delivery
of this Agreement, dMY, the Company, the shareholders of the Company party thereto, and Rainwater, LLC, solely in its capacity as Sellers’ Representative, have entered into a Share Purchase Agreement (as amended or modified from time to time,
the “Share Purchase Agreement”), dated as of the date hereof, pursuant to which, among other transactions, dMY will purchase all the issued and outstanding capital stock of the Company and the Company will become a wholly
owned subsidiary of dMY (such transaction and the other transactions contemplated by the Share Purchase Agreement, the “Transactions”); 

WHEREAS, Article 4.3(b) of dMY’s Amended and Restated Certificate of Incorporation (the “dMY Charter”) provides
that, automatically on the closing of a Business Combination (as defined in the dMY Charter), each share of dMY Class B Common Stock will automatically convert on a
one-for-one basis into shares of dMY Class A Common Stock; provided that, if, in connection with the consummation of a Business Combination, additional shares of
dMY Class A Common Stock are issued or deemed issued in excess of the amounts sold in dMY’s initial public offering, the ratio for which the shares of dMY Class B Common Stock shall convert into shares of dMY Class A Common Stock
will be adjusted so that the number of shares of dMY Class A Common Stock issuable upon conversion of all shares of dMY Class B Common Stock will equal, in the aggregate, 25% of the sum of (a) the total number of all shares of dMY
Class A Common Stock issued in dMY’s initial public offering (including any shares of dMY Class A Common Stock issued pursuant to the underwriters’ over-allotment option) plus (b) the sum of (i) all shares of dMY
Class A Common Stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued in connection with or in relation to the consummation of the Business Combination (including
any shares of dMY Class A Common Stock issued pursuant to a forward purchase agreement), excluding any shares of dMY Class A Common Stock or equity-linked securities or rights issued, or to be issued, to any seller in the Business
Combination, any private placement warrants issued to the Sponsor, or an affiliate of the Sponsor or dMY’s officers and 

 
directors upon the conversion of working capital loans made to dMY and any warrants issued pursuant to a forward purchase agreement, minus (ii) the number of shares of dMY Class A
Common Stock redeemed in connection with a Business Combination, provided that such conversion of shares of dMY Class B Common Stock shall never be less than on a
one-for-one basis (the “Conversion Rights Provision”); 

WHEREAS, under the dMY Charter, the Transactions may trigger the Conversion Rights Provision; 

WHEREAS, in connection with the Transactions, the parties hereto desire that each dMY Holder irrevocably waives his, her or its rights under Article 4.3(b) of
the dMY Charter with respect to any additional shares of dMY Class A Common Stock otherwise issuable upon conversion pursuant to the Conversion Rights Provision (the “Excess Shares”); and 

WHEREAS, as an inducement to dMY and the Company to enter into the Share Purchase Agreement and to consummate the transactions contemplated therein, the
parties hereto desire to agree to certain matters as set forth herein. 
 AGREEMENT 

NOW, THEREFORE, in consideration of the foregoing, in order to induce the Company and dMY to enter into the Share Purchase Agreement and for other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree, as follows: 
 Article I.

 SPONSOR SUPPORT AGREEMENT; COVENANTS 

Section 1.01 Binding Effect of Share Purchase Agreement. Each dMY Holder hereby acknowledges that it has read the Share Purchase Agreement and
this Agreement and has had the opportunity to consult with its tax and legal advisors. During the period commencing on the date hereof and ending on the earlier to occur of (a) the Closing and (b) such date and time as the Share Purchase
Agreement shall be terminated in accordance with Section 9.1 thereof (the “Expiration Time”), each dMY Holder shall be bound by and comply with Section 6.5 (Public Announcements), Section 6.9 (Trust) and
Section 10.3 (No Survival of Representations, Warranties, Covenants and Agreements) of the Share Purchase Agreement (and any relevant definitions contained in such Section) as if (a) the Sponsor or such Insider was an original signatory to
the Share Purchase Agreement with respect to such provision and (b) each reference to dMY contained in such provisions also referred to such dMY Holder. 

Section 1.02 Competing Transaction. From the date hereof until the Expiration Time, each dMY Holder (i) shall not take, and shall cause its
Affiliates and their respective Representatives, not to take, any action to solicit, encourage, initiate or engage in discussions or negotiations with, or provide any information to or enter into any agreement with any Person (other than the Sellers
and/or any of their Affiliates) concerning any Business Combination Transactions and (ii) shall, and shall cause its Affiliates and their respective Representatives to, immediately cease and cause to be terminated all existing discussions,
conversations, negotiations and other communications with any Person (other than the Sellers and their Affiliates) with respect to any of the foregoing. 

Section 1.03 No Transfer. From the date hereof until the Expiration Time, no dMY Holder shall, (i) sell, offer to sell, contract or agree to
sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, file (or participate in the filing of) a registration statement with the SEC (other than the Registration Statement) or
establish or increase a put equivalent 

  
 2 

 
position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act, with respect to any Subject Securities, (ii) deposit any Subject
Securities into a voting trust or enter into a voting agreement or arrangement or grant any proxy or power of attorney with respect thereto that is inconsistent with this Agreement, or (iii) enter into any swap or other arrangement that
transfers to another, in whole or in part, any of the economic consequences of ownership of any Subject Shares, (clauses (i), (ii) and (iii), collectively, a “Transfer”), except, in each case, for any Transfers of Subject Securities
from a dMY Holder (x) who is an entity, (A) to any partner, member or Affiliate thereof or (B) to dMY’s officers or directors, any affiliate or family member of any of dMY’s officers or directors, any affiliate of the
Sponsor or to any members of the Sponsor or any of their affiliates and (y) who is an individual, (A) to any member of such dMY Holder’s immediate family, or to a trust for the benefit of such dMY Holder or any member of the immediate
family of such dMY Holder, the sole trustees of which are such dMY Holder or any member of such dMY Holder’s immediate family, an affiliate of such dMY Holder or to a charitable organization, (B) by will, other testamentary document or
under the Laws of intestacy upon the death of such dMY Holder or (C) pursuant to a qualified domestic relations order (a “Permitted Transfer”); provided, however, that any Permitted Transfer shall be permitted only if, as a
precondition to such Transfer, the transferee also agrees in a writing, reasonably satisfactory in form and substance to the Company, to assume all of the obligations of such dMY Holder under, and be bound by all of the terms of, this Agreement;
provided, further, that any Transfer permitted under this Section 1.03 shall not relieve such dMY Holder of its obligations under this Agreement. Any Transfer in violation of this Section 1.03 with
respect to the Subject Securities of any dMY Holder shall be void ab initio and of no force or effect. 
 Section 1.04 New Shares. In the event
that, during the period commencing on the date hereof and ending at the Expiration Time, (a) any Subject Securities are issued to any dMY Holder after the date of this Agreement pursuant to any stock dividend, stock split, recapitalization,
reclassification, combination or exchange of Subject Securities or otherwise, (b) any dMY Holder purchases or otherwise acquires beneficial ownership of any Subject Securities or (c) any dMY Holder acquires the right to vote or share in
the voting of any Subject Securities (collectively the “New Securities”), then such New Securities acquired or purchased by such dMY Holder shall be subject to the terms of this Agreement to the same extent as if they constituted
the Subject Securities owned by such dMY Holder as of the date hereof. 
 Section 1.05 Sponsor Agreements. 

 

	 	(a)	 Hereafter until the Expiration Time, at any meeting of the holders of dMY Common Stock (or any adjournment or
postponement thereof), or in any other circumstance in which the vote, consent or other approval of the holders of dMY Common Stock is sought, each dMY Holder shall vote (or cause to be voted), or execute and deliver a written consent (or cause a
written consent to be executed and delivered) covering, all of its, his, or her dMY Voting Shares: 

  

	 	(i)	 against any business combination agreement or merger (other than the Share Purchase Agreement and the
Transactions), consolidation, combination, sale of substantial assets, reorganization, recapitalization, dissolution, liquidation or winding up of or by dMY; 

  

	 	(ii)	 against any proposal, action or agreement that would (A) materially impede, frustrate, prevent or nullify
any provision of this Agreement, the Share Purchase Agreement or the Transactions, (B) result in a breach in any respect of any covenant, representation, warranty or any other obligation or agreement of dMY under the Share Purchase Agreement or
(C) result in any of the conditions set forth in Article VIII or Section 2.2 of the Share Purchase Agreement not being fulfilled. 

  
 3 

	 	(b)	 Hereafter until the Expiration Time, each dMY Holder hereby unconditionally and irrevocably agrees that such
dMY Holder, as applicable, shall: 

  

	 	(i)	 not commit or agree to take any action inconsistent with the foregoing covenants set forth in
Section 1.05(a); and 

  

	 	(ii)	 not redeem any shares of dMY Common Stock owned by such dMY Holder in connection with the Redemption Offer.

 Section 1.06 Waiver of Conversion Ratio Adjustment. 

 

	 	(a)	 As of and conditioned upon the Closing, each dMY Holder hereby irrevocably relinquishes and waives any and all
rights such dMY Holder has or will have under Section 4.3(b)(ii) of dMY Charter to receive any Excess Shares upon conversion of any of the dMY Class B Common Stock held by him, her or it, as applicable, in connection with the Closing.

  

	 	(b)	 Each dMY Holder hereby acknowledges and agrees that, to the extent such dMY Holder receives any Excess Shares
as a result of any conversion of shares of dMY Class B Common Stock, such dMY Holder shall surrender such shares, including any certificates thereof, to dMY for cancellation, and no consideration shall be payable to such dMY Holder in
connection therewith. 

  

	 	(c)	 Each dMY Holder hereby acknowledges and agrees that, immediately prior to the Closing, and subject to
Section 1.06(a), each share of dMY Class B Common Stock that is issued and outstanding as of such time shall automatically convert in accordance with the Conversion Rights Provision into one share of dMY Class A
Common Stock, and each dMY Holder jointly and severally agree that as a result of such conversion, all outstanding shares of dMY Class B Common Stock shall collectively convert on a one-for-one basis into shares of dMY Class A Common Stock (subject to ordinary equitable adjustments on account of any share split, reverse share split or similar equity restructuring transaction).

 Section 1.07 Consent to Disclosure. Each dMY Holder hereby consents to the publication and disclosure in the Registration
Statement (and, as and to the extent otherwise required by applicable securities Laws or the SEC or any other securities authorities, any other documents or communications provided by the Company or dMY to any Governmental Entity or to
securityholders of dMY) of the identity of the Sponsor or such Insider, as applicable, and beneficial ownership of Subject Securities and the nature of such Company Stockholder’s commitments, arrangements and understandings under and relating
to this Agreement and, if deemed appropriate by the Company or dMY, a copy of this Agreement. 
 Article II. 

REPRESENTATIONS AND WARRANTIES 
 Each dMY Holder
represents and warrants as of the date hereof (or the date such dMY Holder becomes a party hereto) to dMY and the Company (solely with respect to such dMY Holder and not with respect to any other dMY Holder) as follows: 

Section 2.01 Organization; Due Authorization. If such dMY Holder is not a natural person, such dMY Holder is duly organized, validly existing and
in good standing under the Laws of the jurisdiction in which it is incorporated, formed, organized or constituted, and the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby are within
such dMY Holder’s corporate, limited liability company or organizational powers and have been duly authorized by 

  
 4 

 
all necessary corporate, limited liability company or organizational actions on the part of such dMY Holder. If such dMY Holder is an individual, such dMY Holder has full legal capacity, right
and authority to execute and deliver this Agreement and to perform his or her obligations hereunder. This Agreement has been duly executed and delivered by such dMY Holder and, assuming due authorization, execution and delivery by the other parties
to this Agreement, this Agreement constitutes a legally valid and binding obligation of such dMY Holder, enforceable against such dMY Holder in accordance with the terms hereof (subject to the Remedies Exception). If this Agreement is being executed
in a representative or fiduciary capacity, the Person signing this Agreement has full power and authority to enter into this Agreement on behalf of such dMY Holder. 

Section 2.02 Ownership. Such dMY Holder is the record and beneficial owner (as defined in the Securities Act) of, and has good title to, all of
the Subject Securities listed across from such dMY Holder’s name on Schedule I hereto, and there exist no Liens or any other limitation or restriction (including any restriction on the right to vote, sell or otherwise dispose of such
Subject Securities (other than transfer restrictions under the Securities Act)) affecting any such Subject Securities, other than Liens pursuant to (i) this Agreement, (ii) the dMY Organizational Documents, (iii) the Share Purchase
Agreement, (iv) that certain Letter Agreement, dated as of October 5, 2021, by and among dMY, the dMY Holders and the other parties thereto (the “IPO Letter Agreement”) or (v) any applicable securities Laws. The
Subject Securities are the only equity securities in dMY owned of record or beneficially by such dMY Holder on the date of this Agreement, and none of the Subject Securities held by such dMY Holder are subject to any proxy, voting trust or other
agreement or arrangement with respect to the voting of such Subject Securities, except as provided hereunder and under the IPO Letter Agreement. Such dMY Holder has full voting power with respect to the Subject Securities held by such dMY Holder.
Other than the Subject Securities held by such dMY Holder, such dMY Holder does not hold or own any rights to acquire (directly or indirectly) any equity securities of dMY or any equity securities convertible into, or which can be exchanged for
equity securities of dMY. 
 Section 2.03 No Conflicts. The execution and delivery of this Agreement by such dMY Holder does not, and the
performance by such dMY Holder of its obligations hereunder will not, (i) conflict with or result in a violation of the organizational documents of such dMY Holder, (ii) require any consent or approval that has not been given or other
action that has not been taken by any Person (including under any contract binding upon such dMY Holder or such dMY Holder’s Subject Securities), in each case, to the extent such consent, approval or other action would prevent, enjoin or
materially delay the performance by such dMY Holder of its obligations under this Agreement or (iii) conflict with or violate any Law. 

Section 2.04 Litigation. Except as would not have, and would not reasonably be expected to have, individually or in the aggregate, a Purchaser
Material Adverse Effect: (a) there are no Actions pending against such dMY Holder, or to the knowledge of such dMY Holder threatened against such dMY Holder, seeking to prevent the Transactions; and (b) there are no Orders pending against
such dMY Holder, or to the knowledge of such dMY Holder threatened against such dMY Holder or to which the dMY Holder is otherwise a party, in each case relating to this Agreement, the Share Purchaser Agreement or the Transactions. 

Section 2.05 Brokerage Fees. Except as set forth on Section 5.9 of the Purchaser Disclosure Schedule to the Share Purchase Agreement, no
Person has acted, directly or indirectly, as a broker, finder, investment banker or financial advisor for dMY in connection with the Transactions, and no Person is or will be entitled to any brokerage, finder’s or other fee, commission or like
payment in respect thereof in connection with the Transactions or based upon arrangements made by or on behalf of dMY. 

  
 5 

 Section 2.06 Acknowledgment. Such dMY Holder understands and acknowledges that each of dMY and
the Company is entering into the Share Purchase Agreement in reliance upon such dMY Holder’s execution and delivery of this Agreement. 

Article III. 
 MISCELLANEOUS 

Section 3.01 Termination. 
  

	 	(a)	 This Agreement and all of its provisions (other than those provisions which expressly survive the Closing, as
set forth in this Article III, collectively, the “Surviving Provisions”) shall terminate and be of no further force or effect upon the earliest of (i) the Expiration Time, and (ii) the written agreement of the Sponsor,
dMY, and the Company. 

  

	 	(b)	 Upon any termination of this Agreement in the entirety, all obligations of the parties under this Agreement
will terminate, without any liability or other obligation on the part of any party hereto to any Person in respect hereof or the transactions contemplated hereby, and no party hereto shall have any claim against another (and no person shall have any
rights against such party), whether under contract, tort or otherwise, with respect to the subject matter hereof; provided, however, that the termination of this Agreement shall not relieve any party hereto from liability arising in respect of any
breach of this Agreement prior to such termination. 

  

	 	(c)	 Notwithstanding anything to the foregoing, this Article III shall survive the termination of this Agreement.

 Section 3.02 Governing Law. The Law of the State of Delaware shall govern (a) all claims or matters related to or
arising from this Agreement (including any tort or non-contractual claims) and (b) any questions concerning the construction, interpretation, validity and enforceability of this Agreement, and the
performance of the obligations imposed by this Agreement, in each case without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of
the Law of any jurisdiction other than the State of Delaware. 
 Section 3.03 CONSENT TO JURISDICTION AND SERVICE OF PROCESS; WAIVER OF JURY
TRIAL. 
  

	 	(a)	 Each party hereto submits to the exclusive jurisdiction of first, the Court of Chancery of the State of
Delaware or if such court declines jurisdiction, then to any court of the State of Delaware or the Federal District Court for the District of Delaware, in any Proceeding arising out of or relating to this Agreement, agrees that all claims in respect
of the Proceeding shall be heard and determined in any such court and agrees not to bring any Proceeding arising out of or relating to this Agreement in any other courts. Nothing in this Section 3.03, however, shall affect
the right of any party to serve legal process in any other manner permitted by Law or at equity. Each party hereto agrees that a final judgment in any Proceeding so brought shall be conclusive and may be enforced by suit on the judgment or in any
other manner provided by Law or at equity. 

  

	 	(b)	 WAIVER OF TRIAL BY JURY. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHTS TO TRIAL BY JURY IN ANY
PROCEEDING BROUGHT TO RESOLVE ANY DISPUTE BETWEEN OR AMONG ANY OF THE PARTIES (WHETHER ARISING IN CONTRACT, TORT OR OTHERWISE) ARISING OUT OF, CONNECTED WITH, RELATED OR INCIDENTAL TO THIS AGREEMENT, THE TRANSACTIONS OR

  
 6 

	 	
THE RELATIONSHIPS ESTABLISHED AMONG THE PARTIES UNDER THIS AGREEMENT. EACH PARTY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH
PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL. 

 Section 3.04
Assignment. This Agreement and all of the provisions hereof will be binding upon and inure to the benefit of the parties hereto and their respective heirs, successors and permitted assigns. Neither this Agreement nor any of the rights,
interests or obligations hereunder will be assigned (including by operation of law) without the prior written consent of the parties hereto. Any purported assignment or delegation not permitted under this Section 3.04 shall
be null and void. 
 Section 3.05 Specific Performance. The parties hereto agree that irreparable damage would occur in the event any provision
of this Agreement was not performed in accordance with the terms hereof and that the parties shall be entitled to specific performance of the terms hereof, in addition to any other remedy at law or in equity without the necessity of proving the
inadequacy of money damages as a remedy and without bond or other security being required, this being in addition to any other remedy to which they are entitled at law or in equity. Each of the parties hereto hereby further acknowledges that the
existence of any other remedy contemplated by this Agreement does not diminish the availability of specific performance of the obligations hereunder or any other injunctive relief. It is accordingly agreed that the parties hereto shall be entitled
to seek an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in the chancery court or any other state or federal court within the State of Delaware, this being in
addition to any other remedy to which such party is entitled at law or in equity. Each party hereto hereby further agrees that in the event of any action by any other party for specific performance or injunctive relief, it will not assert that a
remedy at law or other remedy would be adequate or that specific performance or injunctive relief in respect of such breach or violation should not be available on the grounds that money damages are adequate or any other grounds. 

Section 3.06 Amendment, Waiver. This Agreement may not be amended, changed, supplemented, waived or otherwise modified or terminated (other than
to correct a typographical error) as to any particular provision, except by a written instrument executed by all parties hereto. 
 Section 3.07
Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable Law, but if any provision of this Agreement or the application of any such provision to any
Person or circumstance shall be held to be prohibited by or invalid, illegal or unenforceable under applicable Law in any respect by a court of competent jurisdiction, such provision shall be ineffective only to the extent of such prohibition or
invalidity, illegality or unenforceability, without invalidating the remainder of such provision or the remaining provisions of this Agreement. Furthermore, in lieu of such illegal, invalid or unenforceable provision, there shall be added
automatically as a part of this Agreement a legal, valid and enforceable provision as similar in terms to such illegal, invalid, or unenforceable provision as may be possible. 

Section 3.08 Notices. All notices, demands and other communications to be given or delivered under this Agreement shall be in writing and shall be
deemed to have been given (a) when personally delivered (or, if delivery is refused, upon presentment) or received by email prior to 6:00 p.m. eastern time on a Business Day and, if otherwise, on the next Business Day, (b) one (1) Business
Day following sending by reputable overnight express courier (charges prepaid) or (c) three (3) days following mailing by certified or registered mail, postage prepaid and return receipt requested. Unless another address is specified in writing
pursuant to the provisions of this Section 3.08, notices, demands and other communications to the Parties shall be sent to the addresses indicated below: 

  
 7 

 If to dMY: 

dMY Technology Group, Inc. VI 

1180 North Town Center Drive, Suite 100 

Las Vegas, Nevada 89144 

Attention: Niccolo de Masi; Harry L. You 

Email: niccolo@dmytechnology.com; harry@dmytechnology.com 

with a copy to (which will not constitute notice): 

Cleary Gottlieb Steen & Hamilton LLP 

One Liberty Plaza 
 New York NY
10006 
 Attention: Kyle A. Harris; Adam Brenneman 

E-mail: kaharris@cgsh.com; abrenneman@cgsh.com 

If to the Company: 
 Rain
Enhancement Technologies, Inc. 
 21 Pleasant Street, Suite 237 

Newburyport, MA 01950 
 Attention:
Paul Dacier 
 E-mail: paul@rainwatertech.com 

with a copy to (which shall not constitute notice): 

TCF Law Group, PLLC 
 21 Pleasant
Street, Suite 237 
 Newburyport, MA 01950 

Attention: Stephen J. Doyle 

Email: sdoyle@tcflaw.com 
 If
to a dMY Holder: 
 To such dMY Holder’s address set forth in Schedule I 

with a copy to (which will not constitute notice): 

Cleary Gottlieb Steen & Hamilton LLP 

One Liberty Plaza 
 New York NY
10006 
 Attention: Kyle A. Harris; Adam Brenneman 

E-mail: kaharris@cgsh.com; abrenneman@cgsh.com 

  
 8 

 Section 3.09 Capacity. Each dMY Holder is signing this Agreement solely in such dMY
Holder’s capacity as a holder of Subject Securities, and not in such dMY Holder’s capacity as a director, officer or employee of dMY or in such dMY Holder’s capacity as a trustee or fiduciary of any employee benefit plan or trust.
Notwithstanding anything herein to the contrary, nothing herein shall in any way restrict a director or officer of dMY in the exercise of his or her fiduciary duties as a director or officer of dMY or in his or her capacity as a trustee or fiduciary
of any employee benefit plan or trust or prevent or be construed to create any obligation on the part of any director or officer of dMY or any trustee or fiduciary of any employee benefit plan or trust from taking any action in his or her capacity
as such director, officer, trustee or fiduciary, provided that nothing contained in this Section 3.09 shall obviate any of such dMY Holder’s obligations under Article 1 of this Agreement. 

Section 3.10 Counterparts. This Agreement may be executed in two or more counterparts (any of which may be delivered by electronic transmission),
each of which shall constitute an original, and all of which taken together shall constitute one and the same instrument. 
 Section 3.11 Entire
Agreement. This Agreement and the agreements referenced herein constitute the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and supersede all prior understandings, agreements or representations
by or among the parties hereto to the extent they relate in any way to the subject matter hereof. 
 [Signature Page Follows] 

  
 9 

 IN WITNESS WHEREOF, the dMY Holders, dMY, and the Company have each caused this Sponsor Support Agreement to
be duly executed as of the date first written above. 
  

			
	SPONSOR:
	
	DMY SPONSOR VI, LLC
		
	By:	 	 /s/ Harry L. You

		 	Name: Harry L. You
		 	Title: Manager
	
	INSIDERS:
		
	By:	 	 /s/ Harry L. You

		 	Name: Harry L. You
		
	By:	 	 /s/ Niccolo de Masi

		 	Name: Niccolo de Masi
	
	DMY:
	DMY TECHNOLOGY GROUP, INC. VI
		
	By:	 	 /s/ Niccolo de Masi

		 	Name: Niccolo de Masi
		 	Title: Chief Executive Officer
	
	COMPANY:
	
	RAIN ENHANCEMENT TECHNOLOGIES, INC.
		
	By:	 	 /s/ Paul T. Dacier 

		 	Name: Paul T. Dacier
		 	Title: Executive Chairman

 [Signature Page to Sponsor Support Agreement]EX-10.1

 Exhibit 10.1 

EMPLOYMENT AGREEMENT 

This Employment Agreement (this “Agreement”) made and entered into this 21st day of December, 2022 (the “Effective
Date”), by and between Fiserv, Inc., a Wisconsin corporation (the “Company”), and Frank Bisignano (“Executive”). 

WITNESSETH: 

WHEREAS, Executive is currently the Chairman, President and Chief Executive Officer of the Company pursuant to that certain Amended and
Restated Employment Agreement, dated as of January 16, 2019, and as amended on May 7, 2020 and on August 10, 2021, by and between the Company and Executive (the “Prior Agreement”); 

WHEREAS, Executive and the Company desire to enter into this new Agreement, which will replace and supersede the Prior Agreement in its
entirety; and 
 WHEREAS, the Company wishes to continue to employ Executive, and Executive desires to continue employment, pursuant
to the terms and conditions set forth in this Agreement. 
 NOW THEREFORE, in consideration of the mutual covenants hereinafter set
forth, the parties agree as follows: 
  

	1.	 Term of Employment. 

1.1 Term. Commencing on the Effective Date, the Company agrees to continue to employ Executive, and Executive agrees to accept such
continued employment and serve the Company, in such capacities, with such duties and authority, for such period, at such level of compensation and with such benefits, and upon such other terms and subject to such other conditions, as are hereinafter
set forth. The term of Executive’s employment shall commence on the Effective Date, and end on the fifth (5th) anniversary thereof, subject to earlier termination or further renewal as
provided in this Agreement (the “Term of Employment”). 
 1.2 Renewal and Effect of
Non-Renewal. Executive’s Term of Employment shall automatically renew for subsequent one (1) year periods, subject to the terms of this Agreement, unless either party gives written notice ninety
(90) days or more prior to the expiration of the then existing Term of Employment of Executive’s or the Company’s decision not to renew. A decision by the Company not to renew other than as a result of Executive’s death or
Disability (as defined below), and other than in circumstances which would give rise to a termination for Cause (as defined below), shall be treated as a Termination by the Company without Cause and so governed by Paragraph 5.3.5 below. A decision
by Executive not to renew, other than for Good Reason (as defined below), shall be treated as a Voluntary Resignation, and so governed by the provisions of Paragraph 5.3.4 below. 

 

	2.	 Capacities, Duties and Authority. 

2.1 Title and Duties. During the Term of Employment, Executive shall serve as the Company’s President and Chief Executive Officer.
Executive shall report directly to the Company’s Board of Directors (the “Board”) and shall have such duties, functions, and responsibilities as contemplated by the Company’s by-laws
and as the Board shall designate, provided, that such duties, functions and responsibilities are commensurate with Executive’s positions of President and Chief Executive Officer. 

 2.2 Obligations. Executive shall serve the Company faithfully, conscientiously, and
to the best of Executive’s ability and shall promote the interests and reputation of the Company. Unless prevented by sickness or Disability or during a period of vacation or other approved leave of absence, Executive shall devote substantially
all of Executive’s time, attention, knowledge, energy, and skills, during normal working hours, and at such other times as Executive’s duties may reasonably require, to the duties of Executive’s employment; provided,
however, that it shall not be a breach of this Agreement for Executive to manage his own private financial investments, to serve on civic or charitable boards, or to continue to serve on corporate boards consistent with this Agreement, the
Executive’s other agreements with the Company and the Company’s policies; provided, further, that all such activities do not materially interfere with Executive’s performance of his duties hereunder, cause harm or
concern to the Company’s operations, profitability or reputation, or otherwise violate this Agreement. 
 2.3 Service on Board.
As of the Effective Date, Executive is a member of the Board. During the Term of Employment, the Company shall designate and nominate Executive for election by the Company’s shareholders to the Board in accordance with Article IX,
Section 2(a) of the Company’s by-laws, as amended from time to time. 
 2.4 No
Limitation on Ability to Perform. Executive represents and warrants that he is not a party to, or otherwise bound by, any agreement, covenant, or other restriction that would in any way conflict with or limit his ability to perform his duties
hereunder. 
 2.5 Reimbursement of Business Expenses. During the Term of Employment, subject to and in accordance with the
Company’s policies with regard to such matters applicable to Executive, Executive is authorized to incur reasonable business expenses in carrying out his duties and responsibilities under the Agreement, and the Company shall promptly reimburse
him for all such properly documented business expenses incurred in accordance with the Company’s travel and business expense reimbursement policy applicable to Executive in connection with carrying out the business of the Company. 

 

	3.	 Compensation. 

3.1 Base Salary. Executive shall be paid a base salary at the annual rate of $1,320,000 through December 31, 2022, and at the
annual rate of $1,400,000 from and after January 1, 2023, payable semi-monthly and otherwise in accordance with the regular payroll practices of the Company. At least annually, during the Term of Employment, the Talent and Compensation
Committee of the Board (the “Committee”) shall consider and appraise relevant external market data and the contributions of Executive to the Company, at such time as the contributions of other senior executives of the Company and
adjustments to base compensation are considered or made, and due consideration shall be given to the upward adjustment of Executive’s annual base salary, which evaluation and adjustment to base compensation shall be done at such time as the
salaries of the other senior executives of the Company are evaluated; provided no such consideration and appraisal shall occur with respect to the 2023 calendar year. During the Term of Employment, Executive’s base salary shall not be
decreased. 

  
 2 

 3.2 Target Annual Incentive. Each calendar year during the Term of Employment,
commencing with 2023, the Board (or the Committee) shall annually award to the Executive an annual cash incentive opportunity with a target payout of at least $2,500,000 (the “Target Annual Incentive”) at the same time and on
consistent terms as such annual cash incentives are awarded to other similarly situated senior executive officers of the Company. For the 2022 calendar year, Executive shall remain entitled to the payment of the annual cash incentive opportunity, if
earned, as previously communicated to Executive. 
 3.3 Equity Awards. Executive shall be entitled to receive equity awards under the
Company’s Amended and Restated 2007 Omnibus Incentive Plan or any successor plan thereto (the “Plan”) as approved by the Board (or the Committee) from time to time. 

3.4 Paid Time Off. Executive shall be entitled to take annual vacation without loss or diminution of compensation consistent with the
reasonable needs of the Company’s business and such vacation policies of the Company in effect from time to time, or as may otherwise be established by the Board. Executive shall further be entitled to the number of paid holidays, and leaves
for illness or temporary disability in accordance with the policies of the Company for its senior executives, as the Company may amend or terminate such policies from time to time in its sole discretion. 

 

	4.	 Employee Benefit Programs. 

4.1 General Benefits. During the Term of Employment, Executive shall be eligible to participate in and shall have the benefit of all
the Company’s group medical, dental, and vision plans and programs, group life and disability insurance plans, the Company’s 401(k) plan, and other employee benefit plans and standard benefits as are or may be generally made available to
senior executives of the Company. 
 4.2 Other Benefits. Executive shall be entitled to receive such executive perquisites, fringe,
and other benefits as are provided to senior executives of the Company and their families generally under any of the Company’s plans and programs in effect from time to time and such other benefits as are customarily available to executives of
the Company and their families. In addition, Executive shall be provided with the following perquisites: (i) travel on a private aircraft when Executive travels on business on behalf of the Company, (ii) reasonable non-exclusive use of the Company’s private aircraft for personal travel for Executive and his family (any income from which shall be imputed to the Executive at Standard Industry Fare Level rates in accordance
with Treasury Regulation Section 1.61-21(g)(5)), (iii) use of a car and driver, and (iv) financial planning. 

4.3 No Other Benefit Obligations. Except as otherwise expressly provided in this Agreement, nothing in this Section 4 shall be
construed to require the Company to establish, maintain, or continue any compensation or benefit plan, program, or arrangement. 

  
 3 

 4.4 Company’s Right to Amend or Terminate Benefit Programs. Except as otherwise
expressly provided by their terms, such compensation or benefit plans, programs, or arrangements are subject to modification or termination by the Company at any time. 
  

	5.	 Termination of Employment. 

5.1 Termination Events. Executive’s employment shall terminate: 

5.1.1 upon the death of the Executive; 

5.1.2 upon the Disability (as defined below) of Executive, effective upon the giving of a written Notice of Termination in accordance with
Paragraph 5.2 below. The Company shall have the right to terminate Executive under this Paragraph 5.1.2 if and only if, during the Term of Employment, as a result of Executive’s disability due to physical or mental illness or injury (regardless
of whether such illness or injury is job-related) which qualifies as a disability under the Company’s long-term disability plan (“Disability”), Executive shall have been absent from
Executive’s duties hereunder on a full-time basis for a period of six (6) consecutive months, and, within thirty (30) days after the Company notifies Executive in writing that it intends to terminate Executive’s employment (which
notice shall not constitute the Notice of Termination described in Paragraph 5.2), Executive shall not have returned to the performance of Executive’s duties hereunder on a full-time basis; 

5.1.3 at the option of the Company, and subject to Executive’s rights to notice and opportunity to cure as set forth in Paragraph 5.2
below, for Cause, effective on a date specified in the Notice of Termination. For purposes of this Agreement, “Cause” shall mean any of the following: 

(a) Executive’s dishonesty or similar serious misconduct directly related to the performance of Executive’s duties and
responsibilities hereunder, which results from a willful act or omission and which is materially injurious to the operations, financial condition or business reputation of the Company; 

(b) Executive’s conviction of a misdemeanor involving moral turpitude or of a felony; 

(c) Executive’s drug or alcohol abuse which materially impairs the performance of his duties and responsibilities as set forth herein;

 (d) substantial continuing willful and unreasonable inattention to, neglect of, or refusal by Executive to perform Executive’s
duties and responsibilities under this Agreement; 
 (e) Executive’s willful or intentional material violation of a material provision
of the Company’s Code of Conduct, as it may be amended from time to time, or other material Company policies in effect from time to time; or 

(f) any other willful or intentional material breach or breaches of this Agreement by Executive. 

  
 4 

 5.1.4 at the option of the Company, for a reason other than death, Disability or Cause,
effective upon the giving of a Notice of Termination in accordance with Paragraph 5.2 of this Agreement; 
 5.1.5 at the option of
Executive, and subject to the Company’s rights to notice and opportunity to cure as set forth in Paragraph 5.2(d) below, for Good Reason. For purposes of this Agreement “Good Reason” shall mean the occurrence at any time of any
of the following without Executive’s prior written consent: 
 (a) any breach of this Agreement by the Company, other than an
insubstantial and inadvertent failure not occurring in bad faith that the Company remedies promptly after receipt of notice thereof given by Executive; 

(b) any reduction in Executive’s (x) base salary or (y) Target Annual Incentive; 

(c) the removal of Executive from his position as the Company’s Chief Executive Officer, except in the event that such removal relates to
the termination by the Company of Executive’s employment for Cause or by reason of Disability; 
 (d) a good faith determination by
Executive that there has been a material adverse change, without Executive’s written consent, in Executive’s working conditions or status with the Company, including but not limited to (i) a significant change in the nature or scope
of Executive’s authority, powers, functions, duties or responsibilities as contemplated by Section 2, or (ii) a significant reduction in the level of support services, staff, secretarial and other assistance, office space and
accoutrements, but in each case excluding for this purpose an isolated, insubstantial and inadvertent event not occurring in bad faith that the Company remedies within ten (10) days after receipt of notice thereof given by Executive; 

(e) the relocation of Executive’s principal place of employment to a location more than 35 miles from the greater New York, New York
metropolitan area; or 
 (f) the failure by the Company to obtain an agreement from any successor to the Company to assume this Agreement.

 5.1.6 at the option of Executive, effective thirty (30) days after the giving of written notice to the Company of the exercise of
such option for a reason other than Good Reason as set forth in Paragraph 5.1.5 above (“Voluntary Resignation”). 
 5.2
Termination Notice and Procedure. Any termination by the Company or Executive shall be communicated by a written notice of termination (“Notice of Termination”) to Executive, if such Notice is given by the Company, and to the
Company, if such Notice is given by Executive, all in accordance with the following procedures: 
 (a) if such termination is for Disability,
Cause, or Good Reason, the Notice of Termination shall indicate in reasonable detail the facts and circumstances alleged to provide a basis for such termination. No Notice of Termination for Cause shall be delivered unless the Board has made a good
faith determination, after providing Executive with the opportunity to 

  
 5 

 
appear before the Board and be heard, that the conduct or acts of Executive specified in the Notice of Termination occurred and constitute Cause (as defined in Paragraph 5.1.3), and such Notice
of Termination provides the Executive with an opportunity to cure such conduct or acts as contemplated by Paragraph 5.2(d), below; 
 (b)
any Notice of Termination by the Company shall have been approved, prior to the giving thereof to Executive, by a resolution duly adopted by a majority of the directors of Company (or any successor corporation) then in office excluding Executive;

 (c) if the Notice of Termination is given by Executive for Good Reason, Executive may cease performing his duties hereunder, subject to
the Company’s opportunity to cure below. If the Notice of Termination is given by the Company for Cause, then Executive may cease performing his duties hereunder, subject to Executive’s opportunity to cure pursuant to Paragraph 5.2(d)
below; 
 (d) if the Notice of Termination is given by the Company for Cause, Executive shall have thirty (30) days, or such longer
period as the Company may determine to be appropriate, to cure any conduct or act, if curable, alleged to provide grounds for termination of employment for Cause. If the Notice of Termination is given by Executive for Good Reason, the Company shall
have thirty (30) days, or such longer period as Executive may determine to be appropriate, to cure any conduct or act, if curable, alleged to provide grounds for termination of employment for Good Reason; and 

(e) the recipient of any Notice of Termination shall personally deliver or mail in accordance with Paragraph 8.6 below written notice of any
dispute relating to such Notice of Termination to the party giving such Notice of Termination within fifteen (15) days after receipt thereof; provided, however, that if Executive’s conduct or act alleged to provide grounds
for termination by the Company for Cause is curable, then such period shall be thirty (30) days. After the expiration of such period without a written notice of dispute being provided, the contents of the Notice of Termination shall become
final and not subject to dispute. 
 5.3 Obligations of the Company upon Termination of Employment. 

5.3.1 Death. In the event of Executive’s death during the Term of Employment, the Term of Employment shall end as of the date of
Executive’s death and his estate and/or beneficiaries, as the case may be, shall receive the following, as soon as practicable (unless otherwise provided herein) following the date of Executive’s death: 

(a) (i) all accrued but unpaid base salary for the time period ending with the date of termination; (ii) reimbursement for any and all
monies advanced by Executive for the time period ending with the termination date for all expenses reimbursable by the Company under this Agreement; and (iii) notwithstanding any provision of any cash bonus or incentive compensation plan
applicable to Executive, but subject to any irrevocable deferral election then in effect, a lump sum amount, in cash, equal to the amount of any bonus or incentive compensation that has been allocated or awarded to Executive for a fiscal year or
other measuring period under the plan that ends prior to the date of termination but has not yet been paid (collectively, “Earned Amounts”); 

  
 6 

 (b) provided Executive has been employed at least through July 1 of the year of death,
then notwithstanding any provision of any annual cash incentive compensation plan applicable to Executive, but subject to any irrevocable deferral election then in effect, a lump sum amount, in cash, equal to the amount of any annual cash incentive
compensation earned for the year of Executive’s death based on the level of achievement of the performance goal(s) established with respect thereto, multiplied by a fraction, the numerator of which is the number of days of Executive’s
employment during such year and the denominator of which is the number of days in such year, which amount shall be paid at the same time as other senior executives of the Company are paid under such plan (such amount, the “Pro-Rated Annual Bonus”); 
 (c) full vesting of all equity and long-term grants and awards;
provided, that all awards with performance goals or metrics for which the performance period has not been completed as of the date of Executive’s death will be deemed achieved at the “target” level (the
“Accelerated Equity Vesting”); and 
 (d) such additional benefits, if any, to which Executive is expressly eligible
following the termination of Executive’s employment on account of death, as may be provided by the then-existing plans, programs, and/or arrangements of the Company, including but not limited to the Fiserv, Inc. Executive Severance and Change
of Control Policy (as in effect from time to time, the “Severance Policy”). 
 5.3.2 Disability. If Executive’s
employment is terminated due to Disability during the Term of Employment, either by the Company or by Executive, the Term of Employment shall end as of the date of the termination of Executive’s employment (as provided in Paragraph 5.1.2 of
this Agreement) and Executive shall receive the following, as soon as practicable (unless otherwise provided herein) following the date of termination: 

(a) Earned Amounts (as defined in Paragraph 5.3.1(a)); 

(b) Accelerated Equity Vesting (as defined in Paragraph 5.3.1(c)); 

(c) provided Executive has been employed at least through July 1 of the year of termination, then notwithstanding any provision of any
annual cash incentive compensation plan applicable to Executive, the Pro-Rated Annual Bonus; and 

(d) such additional benefits, if any, to which Executive is expressly eligible following the termination of Executive’s employment on
account of Disability, as may be provided by the then-existing plans, programs, and/or arrangements of the Company, including but not limited to the Severance Policy. 

5.3.3 Cause. If the Company terminates Executive’s employment for Cause in accordance with the terms set forth in Paragraph 5.1.3
above, the Term of Employment shall end as of the effective date of termination and Executive shall receive the following, as soon as practicable (unless otherwise provided herein) following Executive’s date of termination: 

(a) Earned Amounts (as defined in Paragraph 5.3.1(a)); and 

  
 7 

 (b) such additional benefits, if any, to which Executive is expressly eligible following the
termination of Executive’s employment for Cause, as may be provided by the then-existing plans, programs, and/or arrangements of the Company, including but not limited to the Severance Policy. 

5.3.4 Voluntary Resignation. If Executive terminates his employment by Voluntary Resignation, in accordance with the terms set forth in
Paragraph 5.1.6 above, the Term of Employment shall end as of the effective date of termination; and Executive shall receive the following, as soon as practicable following Executive’s date of termination: 

(a) Earned Amounts (as defined in Paragraph 5.3.1(a)); 

(b) if such termination occurs on or following April 28, 2023 (“Retirement Eligibility Date”), subject to
Executive’s execution of a Separation Agreement and Release of all claims related to Executive’s employment or the termination thereof, in a form substantially similar to that used for similarly situated senior executive officers of the
Company, within sixty (60) days following termination (the “Release Requirement”), then: 
 1. provided
Executive has been employed at least through July 1 of the year in which Executive’s termination occurs, the Pro-Rated Annual Bonus (as defined in Paragraph 5.3.1(b)); and 

2. with respect to any awards of performance shares, performance share units or incentive awards for which the performance
period relates to a period of more than one fiscal year of the Company (collectively, “LTIP Performance Awards”) for which the performance period has been in effect for at least six (6) months as of the date of the
Executive’s termination of employment, receipt of the shares or cash due under such award(s) if earned based on the actual level of achievement of the performance goals, as determined at the end of the relevant performance period, specified for
such award(s), multiplied by a fraction, the numerator of which is the number of full months of Executive’s employment during the applicable performance period and the denominator of which is the number of full months in such performance
period, which shares shall be issued or cash amount paid in accordance with the terms of such awards; 
 3. with respect to
all equity awards other than LTIP Performance Awards, (a) any outstanding stock options shall continue to vest on the date or dates that such awards would have vested absent Executive’s termination of employment, and Executive shall have
the right to exercise any outstanding stock options for not less than five (5) years following the date of termination of his employment, but in no event longer than ten (10) years from the date of grant, or if earlier, the latest date the
option could have been exercised had Executive remained in employment, and (b) any awards of restricted stock or restricted stock units shall vest in full on the Executive’s termination of employment; provided that Executive must hold, and
shall not be permitted to transfer, assign, pledge or encumber the shares issued under this subparagraph (b) (net of any shares withheld or sold to cover applicable withholding taxes) until the date that such awards would have vested absent
Executive’s termination of employment, and the Company may enter a stop transfer order or other restrictions with respect to such shares to enforce the holding requirement described herein; and 

  
 8 

 (c) such additional benefits, if any, to which Executive is expressly eligible following the
termination of Executive’s employment by Voluntary Resignation, as may be provided by the then-existing plans, programs, and/or arrangements of the Company, including but not limited to the Severance Policy. 

5.3.5 Without Cause or With Good Reason (Non-Change in Control). If Executive’s employment
is terminated by the Company (other than for death, Disability, or Cause) in accordance with the terms set forth in Paragraph 5.1.4 above, or is deemed to have been so terminated pursuant to Paragraph 1.2 above, or if Executive terminates his
employment with Good Reason in accordance with the terms set forth in Paragraph 5.1.5 above, the Term of Employment shall end as of the effective date of termination and Executive shall receive the following as soon as practicable (unless otherwise
provided herein) following the Executive’s date of termination: 
 (a) Earned Amounts (as defined in Paragraph 5.3.1(a)); 

(b) subject to the Release Requirement: 

1. a lump sum cash payment in an amount equal to two (2) times (the “Severance Multiple”) the sum of
(x) the Executive’s then current annual base salary (disregarding any reduction thereof, if such reduction was the cause of a termination for Good Reason) and (y) the Target Annual Incentive (the “Termination
Payment”); 
 2. with respect to all equity awards other than LTIP Performance Awards, Accelerated Equity Vesting
(as defined in Paragraph 5.3.1(c)), as well as the right to exercise any outstanding stock options for not less than five (5) years following the date of termination of his employment, but in no event longer than ten (10) years from the
date of grant, or if earlier, the latest date the option could have been exercised had Executive remained in employment; 

3. with respect to LTIP Performance Awards, receipt of the shares or cash due under such award(s) if earned based on the
actual level of achievement, as determined at the end of the relevant performance period, of the performance goals specified for such award(s), multiplied by a fraction, the numerator of which is the number of full months of Executive’s
employment during the applicable performance period and the denominator of which is the number of full months in such performance period, which shares shall be issued or cash amount paid in accordance with the terms of such awards; and 

  
 9 

 4. reimbursement of the COBRA or other health insurance premiums paid by
the Executive for two (2) years following the date of termination of his employment, or until the Executive obtains health care coverage through subsequent employment, whichever is earlier (the “COBRA Payments”); 

5. provided Executive has been employed at least through July 1 of the year of termination, then notwithstanding any
provision of any annual cash incentive compensation plan applicable to Executive, the Pro-Rated Annual Bonus; and 

(c) such other benefits, if any, to which Executive is expressly eligible following the termination of Executive’s employment by the
Company without Cause or by Executive with Good Reason, as may be provided by the then existing plans, programs, and/or arrangements of the Company, including the Severance Policy. 

5.3.6 Without Cause or With Good Reason (Change in Control). If Executive’s employment is terminated by the Company (other than
for death, Disability, or Cause) in accordance with the terms set forth in Paragraph 5.1.4 above, or is deemed to have been so terminated pursuant to Paragraph 1.2 above, or if Executive terminates his employment with Good Reason in accordance with
the terms set forth in Paragraph 5.1.5 above, in each case during the two (2)-year period following a change of control (as defined in the Plan), the Term of Employment shall end as of the effective date of termination and Executive shall receive
the amounts and benefits described in Paragraph 5.3.5, subject to the Release Requirement, except that the Severance Multiple shall be increased to 2.99 and the LTIP Performance Awards for which the applicable performance period has not been
completed as of the date of the Executive’s termination will become vested in full (i.e., not pro-rated based on the number of months of service during the period) as of the date of such termination at
the higher of the “target” level or actual achievement, treating the date of termination as if it were the end of the applicable performance period. 

5.4 Effect of Payment. Except as expressly provided by Paragraph 5.3, any payment or benefit provided under Paragraph 5.3 hereof shall
be in lieu of any other severance, bonus, or other payments, perquisites, or benefits, including any further accruals or vesting thereof, to which Executive might then or, in the future, be eligible pursuant to this Agreement or any statutory or
common law claim. In order to preserve the parties’ respective legal rights in the event of a dispute, Executive acknowledges and agrees that in the event the parties dispute whether Executive shall be eligible for a payment hereunder, such
payment shall not be deemed to be earned or otherwise vest hereunder until such time as the dispute is determined by a final judgment of a court of competent jurisdiction or otherwise resolved. The foregoing shall not be deemed to prohibit a court
of competent jurisdiction from awarding prejudgment interest under circumstances in which it may deem it appropriate to do so. 
 5.5
Timing of Payments. Notwithstanding anything herein to the contrary, the Termination Payment shall be paid to Executive in cash equivalent, and any other payment or benefit hereunder that is deferred compensation (within the meaning of
Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”)) shall be paid or settled, as applicable, on the first day of the seventh (7th) month following the month
in which Executive’s separation from service (within the meaning of Section 409A of the Code) occurs (or, if earlier, the date of 

  
 10 

 
Executive’s death), without interest thereon; provided, that, if on the date of Executive’s separation from service, neither the Company nor any other entity that is considered a
“service recipient” with respect to Executive within the meaning of Code Section 409A has any stock which is publicly traded on an established securities market (within the meaning of Treasury Regulation
Section 1.897-1(m)) or otherwise, then the Termination Payment shall be paid to Executive in cash equivalent, and any other payment or benefit hereunder that is deferred compensation (within the meaning
of Section 409A of the Code) shall be paid or settled, as applicable, within ten (10) business days after Executive’s separation from service. 

With regard to the benefits described in Paragraph 5.3.5(b)(4), following the end of the COBRA continuation period, if such benefits are
provided under a health plan that is subject to Section 105(h) of the Code, benefits payable under such health plan shall comply with the requirements of Treasury Regulation
Section 1.409A-3(i)(1)(iv) and, if necessary, the Company shall amend such health plan to comply therewith. 

5.6 Change in Control of the Company. 

5.6.1 Application of 280G. Upon a change in control as defined in Code Section 280G, notwithstanding any other provision of this
Agreement, if any portion of any payments under this Agreement, or under any other agreement with or plan of the Company (in the aggregate, “Total Payments”), would constitute an “excess parachute payment,” then Executive
shall have the option to have the Total Payments to be made to Executive reduced such that the value of the aggregate Total Payments that Executive is entitled to receive shall be One Dollar ($1) less than the maximum amount which the Executive may
receive without becoming subject to the tax imposed under Section 4999 of the Code. For purposes of this Agreement, the terms “excess parachute payment” and “parachute payments” shall have the meanings assigned to them in
Section 280G of the Code and such “parachute payments” shall be valued as provided therein. Present value for purposes of this Agreement shall be calculated in accordance with Section 1274(b)(2) of the Code. Within forty
(40) days following Executive’s termination of employment or notice by one party to the other of its belief that there is a payment or benefit due Executive that will result in an “excess parachute payment” as defined in
Section 280G of the Code, Executive and the Company, at the Company’s expense, shall obtain the opinion (which need not be unqualified) of nationally recognized tax counsel (“National Tax Counsel”) selected by the
Company’s independent auditors and reasonably acceptable to Executive (which may be regular outside counsel to the Company), which opinion sets forth (A) the amount of the Base Period Income, (B) the amount and present value of Total
Payments, (C) the amount and present value of any excess parachute payments determined without regard to any reduction of Total Payments pursuant to this Section 5 and (D) the net after-tax
proceeds to the Executive, taking into account the tax imposed under Section 4999 of the Code if (x) the Total Payments were reduced in accordance with the first sentence of this Section 5 or (y) the Total Payments were not so
reduced; provided, however, that for purposes of determining whether any Total Payments constitute “excess parachute payments,” the opinion of National Tax Counsel shall take into account all available mitigating
circumstances and strategies under Section 280G of the Code and the Treasury Regulations promulgated thereunder, including, without limitation, applying the reduction for ‘reasonable compensation’ as described in Treasury Regulation Section 1.280G-1, Q&A-39, including any applicable reduction for the value of any covenant not to compete applicable to Executive as described in Treasury Regulation Section 1.280G-1, Q&A-40, and applying the valuation methodology for any applicable nonvested payments described in Treasury Regulation
Section 1.280G-1, Q&A-24(c). 

  
 11 

 5.6.2 Definitions. As used herein, the term “Base Period Income”
means an amount equal to Executive’s “annualized includable compensation for the base period” as defined in Section 280G(d)(1) of the Code. For purposes of such opinion, the value of any noncash benefits or any deferred payment
or benefit shall be determined by the Company’s independent auditors in accordance with the principles of Section 280G(d)(3) and (4) of the Code, which determination shall be evidenced in a certificate of such auditors addressed to
the Company and Executive. The opinion of National Tax Counsel shall be addressed to the Company and Executive and shall be binding upon the Company and Executive. If such National Tax Counsel opinion determines that there would be an excess
parachute payment, then, at Executive’s sole discretion, any payment or benefit determined by such counsel to be includable in Total Payments may be reduced or eliminated as specified by the Executive in writing delivered to the Company within
thirty (30) days of his receipt of such opinion so that under the bases of calculations set forth in such opinion there will be no excess parachute payment. If such National Tax Counsel so requests in connection with the opinion required by
this Section 5, Executive and the Company shall obtain, at the Company’s expense, and the National Tax Counsel may rely on, the advice of a firm of recognized executive compensation consultants as to the reasonableness of any item of
compensation to be received by Executive solely with respect to its status under Section 280G of the Code and the regulations thereunder. 

5.6.3 Costs. The Company agrees to bear all costs associated with, and to indemnify and hold harmless, the National Tax Counsel of and
from any and all claims, damages, and expenses resulting from or relating to its determinations pursuant to this Section 5, except for claims, damages or expenses resulting from the gross negligence or willful misconduct of such firm. 

6. Acknowledgements; Confidential Information; Competitive Activities; Non-Solicitation. 

6.1 Acknowledgements. Executive acknowledges and agrees as follows: 

6.1.1 The Company is in the business of providing financial and payments solutions to merchants, financial institutions and corporate clients
in the United States, and throughout the world. 
 6.1.2 Since the Company and its subsidiaries (collectively and individually referred to
in this Section 6 as the “Fiserv Group Companies”) would suffer irreparable harm if Executive left the Company’s employ and solicited the business and/or employees of the Fiserv Group Companies, or otherwise interfered
with business relationships of the Fiserv Group Companies, it is reasonable to protect the Fiserv Group Companies against such activities by Executive for a limited period of time after Executive leaves the Company. 

6.1.3 The covenants contained in Paragraphs 6.2, 6.3, and 6.4 below are reasonably necessary for the protection of the Fiserv Group Companies
and are reasonably limited with respect to the activities they prohibit, their duration, their geographical scope, and their effect on Executive and the public. The purpose and effect of the covenants simply are to protect the Fiserv Group Companies
for a limited period of time from unfair competition by Executive. 

  
 12 

 6.2 Confidential Information. For the purposes of this Agreement, all confidential or
proprietary information concerning the business and affairs of the Fiserv Group Companies, including, without limitation, all trade secrets, know-how and other information generally retained on a confidential
basis by the Fiserv Group Companies concerning their designs, products, methods, know-how, techniques, systems, engineering data, software codes and specifications, formulae, processes, inventions and
discoveries, business strategies, sales, marketing and business plans, acquisition prospects and targets, capital expenditure forecasts or plans, investor initiatives, incentive plans, targets or MBOs, business assessments or evaluations, HR
assessments or plans, litigation strategies, approaches or theories and settlement plans with regard thereto, organization plans, tax strategies, financial models, public financial disclosure discussions, concerns, approaches or related issues,
international market assessments and strategies, pricing, product plans and the identities of, and the nature of the Fiserv Group Companies’ dealings with, their suppliers and customers, whether or not such information shall, in whole or in
part, be subject to or capable of being protected by patent, copyright or trademark laws, shall constitute “Confidential Information.” Executive acknowledges that he has had and will from time to time have access to and has obtained
and will in the future obtain knowledge of certain Confidential Information, and that improper use or disclosure thereof by Executive, during or after the termination of his employment by the Company, could cause serious injury to the business of
the Fiserv Group Companies. Accordingly, Executive agrees that, unless otherwise required by law, he will forever keep secret and inviolate all Confidential Information which shall have come or shall hereafter come into his possession, and that he
will not use the same for his own private benefit, or directly or indirectly for the benefit of others, and that he will not disclose such Confidential Information to any other person. If the Executive is legally compelled (by deposition,
interrogatory, request for documents, subpoena, civil investigative demand, or similar process) to disclose any of the Confidential Information, he shall provide the Company with prompt prior written notice of such legal requirement, so that the
Fiserv Group Companies may seek a protective order or other appropriate remedy and/or waive compliance with the terms of this Paragraph. In any event, Executive may furnish only that portion of the Confidential Information which Executive is advised
by legal counsel is required, and he shall exercise his best efforts to obtain an order or assurance that confidential treatment will be accorded such Confidential Information as is disclosed. Notwithstanding anything contained herein which may be
to the contrary, the term “Confidential Information” does not include any information which at the time of disclosure or thereafter is generally available to and known by the public, other than as a result of a disclosure directly or
indirectly by Executive. 
 Notwithstanding anything to the contrary contained herein, nothing in this Agreement shall prohibit Executive from reporting
possible violations of federal law or regulation to or otherwise cooperating with or providing information requested by any governmental agency or entity, including, but not limited to, the Department of Justice, the Securities and Exchange
Commission, the Congress, and any agency Inspector General, or making other disclosures that are protected under the whistleblower provisions of federal law or regulation. Executive does not need the prior authorization of the Company to make any
such reports or disclosures and Executive is not required to notify the Company that Executive has made such reports or disclosures. 

  
 13 

 6.3 Competitive Activities and
Non-Solicitation. In addition to the acknowledgments by Executive set forth in Paragraph 6.1 above, Executive acknowledges that the services provided by him for the Company are a significant factor in the
creation of valuable, special and unique assets which are expected to provide the Fiserv Group Companies with a competitive advantage. Accordingly, Executive agrees as follows: 

6.3.1 Commencing on the Effective Date, and thereafter for a period ending twenty-four (24) months following Executive’s date of
termination, Executive shall not, directly or indirectly, on his behalf or on behalf of any other individual, association, or entity, as agent or otherwise: 

(a) contact any of the clients of any of the Fiserv Group Companies for whom Executive directly performed any services or had any direct
business contact for the purpose of soliciting business or inducing such client to acquire any product or service that at any time during the term of this Agreement is provided or under development by the Fiserv Group Companies from any entity other
than the Fiserv Group Companies; 
 (b) contact any of the clients or prospective clients of any of the Fiserv Group Companies whose
identity or other client specific information Executive discovered or gained access to as a result of his access to the Fiserv Group Companies’ Confidential Information for the purpose of soliciting or inducing any of such clients or
prospective clients to acquire any product or service that at any time during the term of this Agreement is provided or under development by any of the Fiserv Group Companies from any entity other than the Fiserv Group Companies; 

(c) use the Fiserv Group Companies’ Confidential Information to solicit, influence, or encourage any clients or potential clients of any
of the Fiserv Group Companies to divert or direct their business to the Executive or any other person, association, or entity by or with whom Executive is employed, associated, engaged as agent, or otherwise affiliated; or 

(d) encourage, induce, or entice any employee of any of the Fiserv Group Companies with access to or possession of Confidential Information of
the Fiserv Group Companies to leave the employment of the Fiserv Group Companies. 
 6.3.2 Commencing on the Effective Date, and for a
period ending twenty-four (24) months following Executive’s date of termination, without the prior written approval of the Board, Executive shall not participate in the management of, be employed by, or own any business enterprise at a
location within the United States that engages in substantial competition with the Company or any of its subsidiaries in the business described in Paragraph 6.1.1 above, where such enterprise’s revenues from any competitive activities amount to
ten percent (10%) or more of such enterprise’s net revenues and sales for its most recently completed fiscal year; provided, however, that nothing in this Paragraph shall prohibit Executive from owning stock or other securities of
a competitor amounting to less than five percent (5%) of the outstanding capital stock of such competitor; provided, further, that if Executive’s termination is for any reason other than by the Company for Cause, (x) and the
Company reasonably believes the Executive is preparing to associate, or has commenced association with a business enterprise that would otherwise be prohibited by this Paragraph 6.3.2, then the Board shall consider such

  
 14 

 
association in good faith and such association shall be deemed to be competitive and prohibited by this Paragraph 6.3.2 only if so unanimously determined by the Board, and (y) at the time of
Executive’s date of termination, the Board, after consultation with Executive, will use its commercially reasonable best efforts to conform the definition of competitor to the Company’s then-current business for purposes of this Paragraph
6.3.2, which may, but is not required to, include a list of potential competitors. 
 6.4 Assignment of Inventions. Executive
acknowledges and agrees as follows: 
 6.4.1 Executive agrees to promptly disclose to the Company any and all discoveries, developments,
inventions, products, services, processes, formulas, and improvements thereof (“Inventions”), whether or not patentable, relating to the products, services, or commercial or other endeavors of the Fiserv Group Companies, which
Executive may invent, discover, develop, or learn in connection with Executive’s employment. Executive agrees that such inventions are the exclusive and absolute property of the Company and that the Company will be the sole and absolute owner
of all intellectual property rights, including patent and any and all other rights in connection therewith. Executive agrees to give all reasonable assistance in the preparation and/or execution of any papers the Company may request to reflect such
interest and to secure patent or other protection for such Inventions. 
 6.4.2 Executive understands that in the course of employment, the
Executive may prepare writings, drawings, diagrams, designs, specifications, manuals, instructions and other materials, and computer code and programs (“Works”). Such Works are “works made for hire” under United States
copyright law and the Company shall be the owner of Executive’s entire right of authorship in such Works. If such Works are deemed by operation of law not to be “works made for hire,” Executive hereby assigns to the Company the
Executive’s entire right of authorship, including copyright ownership, in such Works and agrees to execute any document deemed necessary by the Company in connection therewith. 

6.4.3 Executive is hereby notified that the immunity provisions in Section 1833 of title 18 of the United States Code provide that an
individual cannot be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade secret that is made (1) in confidence to federal, state or local government officials, either directly or
indirectly, or to an attorney, and is solely for the purpose of reporting or investigating a suspected violation of the law, (2) under seal in a complaint or other document filed in a lawsuit or other proceeding, or (3) to Executive’s
attorney in connection with a lawsuit for retaliation for reporting a suspected violation of law (and the trade secret may be used in the court proceedings for such lawsuit) as long as any document containing the trade secret is filed under seal and
the trade secret is not disclosed except pursuant to court order. 
 6.5 Remedies for Breach. In the event of a judicial
determination that Executive has breached his obligations under Paragraphs 6.2, 6.3, or 6.4, in addition to any damages or other relief otherwise available to the Fiserv Group Companies, the Executive shall be obligated to reimburse the Company for
the Termination Payment and any COBRA Payments made to the Executive. In addition, following a judicial determination, the prevailing party shall be entitled to be reimbursed by the non-prevailing party for
reasonable legal fees and expenses incurred by the prevailing party in connection with the judicial proceeding seeking to enforce the provisions of this Section 6. 

  
 15 

 6.6 Automatic Amendment. For the purposes of this Agreement, the period of
restriction of confidentiality or proprietary information and competition is intended to limit disclosure and competition by Executive to the maximum extent permitted by law. If it shall be finally determined by any court of competent jurisdiction
ruling on this Agreement that the scope or duration of any limitation contained in this Agreement is too extensive to be legally enforceable, then the parties hereby agree that the provisions hereof shall be construed to be confined to such scope or
duration (not greater than that provided for herein) as shall be legally enforceable, and the Executive hereby consents to the enforcement of such limitations as so modified. 

6.7 Right to Injunction. Executive acknowledges that any violation by him of the provisions of this Section 6 would cause serious
and irreparable damage to the Fiserv Group Companies. He further acknowledges that it might not be possible to measure such damage in money. Accordingly, Executive agrees that, in the event of a breach or threatened breach by Executive of the
provisions of this Section, the Fiserv Group Companies may seek, in addition to any other rights or remedies, including money damages or specific performance, an injunction or restraining order, without the need to post any bond or other security,
prohibiting Executive from doing or continuing to do any acts constituting such breach or threatened breach. 
 6.8 Superseding
Provisions. The non-competition, non-solicitation, confidentiality, and intellectual property covenants in this Section 6 entirely supersede and are in lieu of
(and, for the avoidance of doubt, are not in addition to) any non-competition, non-solicitation, confidentiality, intellectual property, or similar covenants or
restrictions under the Prior Agreement, or any other agreement entered into prior to the Effective Date, in each case that run in favor of the Company and its affiliates and by which Executive is bound (whether or not such other covenants or
restrictions purport to survive for a longer period of time or to cover a greater geographic area than the covenants contained herein). 
 7. Directors
and Officers Liability Coverage, Indemnification. 
 Executive shall be entitled to coverage under such directors and officers liability
insurance policies maintained from time to time by the Company for the benefit of its directors and officers. The Company shall indemnify and hold Executive harmless, to the fullest extent permitted by the laws of the State of Wisconsin, from and
against all costs, charges, and expenses (including reasonable attorneys’ fees), and shall, consistent with the laws of the State of Wisconsin, provide for the reimbursement of expenses, incurred or sustained in connection with any action,
suit, or proceeding to which Executive or his legal representatives may be made a party by reason of Executive’s being or having been a director, officer, or employee of the Company or any of its affiliates or employee benefit plans. Such
reimbursement shall be made promptly (but in no event later than the end of the calendar year following the year in which the expense was incurred) following Executive’s written request to the Company for reimbursement. The provisions of this
Section 7 shall not be deemed exclusive of any other rights to which Executive seeking indemnification may have under any by-law, agreement, vote of stockholders or directors, or otherwise. The provisions
of this Section 7 shall survive the termination of this Agreement for any reason. 

  
 16 

 8. Miscellaneous. 

8.1 Governing Law; Venue. This Agreement shall be construed and enforced in accordance with the laws of the State of Wisconsin without
reference to principles of conflict of laws. Any legal suit, action, or proceeding against any party hereto arising out of or relating to this Agreement shall be instituted in a federal or state court in the State of Wisconsin, and each party hereto
waives any objection which it may now or hereafter have to the laying of venue of any such suit, action, or proceeding and each party hereto irrevocably submits to the jurisdiction of any such court in any suit, action, or proceeding. 

8.2 Entire Agreement. This Agreement shall incorporate the complete understanding and agreement between the parties with respect to the
subject matter hereof and thereof and supersede any and all other prior or contemporaneous agreements, written or oral, between Executive and the Company or any predecessor thereof, with respect to such subject matter. No provision hereof may be
modified or waived except by a written instrument duly executed by Executive and the Company. On the Effective Date, the Prior Agreement shall terminate and be of no further effect. 

8.3 Code Section 409A. It is intended that any amounts payable under this Agreement and the Company’s and
Executive’s exercise of authority or discretion hereunder shall comply with Section 409A of the Code (including the Treasury regulations and other published guidance relating thereto) so as not to subject Executive to the payment of any
interest or additional tax imposed under Section 409A of the Code. In furtherance of this intent, to the extent that any Treasury regulations, guidance, or changes to Section 409A of the Code after the date of this Agreement would result
in Executive becoming subject to interest and additional tax under Section 409A of the Code, the Company and Executive agree to amend this Agreement in order to bring this Agreement into compliance with Code Section 409A. 

8.4 Withholding. The Company shall be eligible to deduct and withhold from all compensation payable to Executive pursuant to this
Agreement all amounts required to be deducted and withheld therefrom pursuant to any present or future law, regulation, or ordinance of the United States of America or any state or local jurisdiction therein or any foreign taxing jurisdiction. In
addition, if prior to the date of payment of the Termination Payment or other deferred compensation payments or benefits hereunder, the Federal Insurance Contributions Act (FICA) tax imposed under Sections 3101, 3121(a), and 3121(v)(2) of the Code,
where applicable, becomes due with respect to any payment or benefit to be provided hereunder, the Company may provide for an immediate payment of the amount needed to pay Executive’s portion of such tax (plus an amount equal to the taxes that
will be due on such amount) and Executive’s Termination Payment shall be reduced accordingly. 
 8.5 Headings. Section headings
are included in this Agreement for convenience of reference only and shall not affect the interpretation of the text hereof. 

  
 17 

 8.6 Notices. Notices given pursuant to this Agreement shall be in writing and, except
as otherwise provided by Paragraph 5.2 of this Agreement, shall be deemed given when actually received by Executive or actually received by the Company’s Secretary or any officer of the Company other than Executive. If mailed, such notices
shall be mailed by United States registered or certified mail, return receipt requested, addressee only, postage prepaid, if to the Company, to Fiserv, Inc., Attention: Secretary, 255 Fiserv Drive, Brookfield, Wisconsin 53045, or if to Executive, to
the most recent address shown on the records of the Company, or to such other address as the party to be notified shall have theretofore given to the other party in writing. 

8.7 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall constitute an original but all of
which together shall constitute one and the same instrument. Counterparts may be delivered via electronic mail (including .pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other
transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. 

8.8 Assignment. This Agreement may be assigned by the Company to, and shall inure to the benefit of, any successor to substantially all
the assets and business of the Company as a going concern, whether by merger, consolidation, or purchase of substantially all of the assets of the Company or otherwise, provided, that such successor shall assume the Company’s obligations
under this Agreement. 
 8.9 Coordination with Equity Awards. To the extent that the terms of this Agreement conflict with the terms
of any agreement governing any equity award granted to Executive, this Agreement shall prevail (unless the operative instrument expressly, with specific reference to this Agreement, states otherwise) and, to the extent that the benefits provided by
this Agreement are inconsistent with benefits provided under an equity agreement, Executive shall receive the more favorable benefit. 

  
 18 

 IN WITNESS WHEREOF, each of the Company and Executive has executed this Agreement to become
effective on the Effective Date. 
  

									
	 EXECUTIVE
	 	 FISERV, INC.

				
	 By:
	 	 /s/ Frank Bisignano
	 	 By:
	 	 /s/ Adam L. Rosman

		 	 Frank Bisignano
	 		 	 Name:
	 	 Adam L. Rosman

		 		 	 Title:
	 	 Chief Administrative Officer and Chief Legal Officer

 [Signature Page to Employment Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]